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Abstract: 
 
A number of Garcinia species accumulate benzophenone derivatives that may be useful for the 
treatment of breast cancer. The dereplication of new benzophenone derivatives 
from Garcinia species is challenging due to the occurrence of multiple isomers and the known 
compounds found in their extracts. In the current study, a strategy is described using the UPLC-
QTOFMSE technique to identify tentatively the known and uncharacterized benzophenones of 
interest based upon the characteristic fragmentation ions. Several UPLC-QTOFMS peaks (a–ee) 
appeared to contain benzophenone derivatives, and 12 of these peaks contained compounds with 
MS ionization profiles not consistent with previously identified compounds from the seeds 
of Garcinia paucinervis, an endangered Chinese species. The targeted isolation of unidentified 
compounds of interest afforded five new benzophenones, paucinones E–I (1–5), which were 
determined by MS and NMR analysis and ECD spectroscopy. These compounds were evaluated 
for cytotoxicity against three breast cancer cell lines inclusive of MDA-MB-231, SKBR3, and 
MCF-7. These results indicate that the UPLC-QTOFMSE-guided isolation procedure is an 
efficient strategy for isolating new benzophenones from Garcinia species. 
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Article: 
 
Most benzophenones characterized from Garcinia species are representative of two main classes 
of compounds, the polyisoprenylated benzophenones (PIBs) and polycyclic polyprenylated 
acylphloroglucinols (PPAPs), and their structures usually contain a number of prenyl or geranyl 
groups, hydroxy groups, and complex ring systems. The PIBs and PPAPs have exhibited 
biological activities inclusive of cytotoxic effects on human cancer cell lines and antibacterial, 
anti-HIV, anti-inflammatory, and antioxidant effects.(1-7) Benzophenone derivatives 
from Garcinia species are recognized for their structural diversity and significant biological 
activity, leading to the discovery of many new compounds.(8, 9) 
 
Conventional activity-guided isolation from medicinal plants often requires kilogram amounts of 
plant material and is both laborious and costly. Due to the structural similarity among 
the Garcinia benzophenone derivatives, it can be challenging to separate and identify those 
analogues.(10) LC-MS/MS-guided isolation affords fragment ions that can be used in the 
structural elucidation of plant metabolites and has been demonstrated to increase the efficiency 
for natural products discovery.(11-14) This technique has also been used successfully to profile 
the diagnostic daughter ions of PPAPs and PIBs.(10, 15, 16) However, MS/MS experimental 
analysis needs specific precursor ion selection and repeated injections of samples, thus being 
cumbersome when thousands of metabolic constituents are included in an analysis. In recent 
years, the UPLC-QTOFMSE technique was highlighted to assess the highly sensitive and rapid 
analysis of complex multicomponent mixtures.(17) In particular, MSE spectrometric data with 
parallel alternating scans are acquired at either low collision energy to obtain precursor ion 
information or high collision energy to generate the precursor ion and fragment ions, providing 
similar information to conventional MS/MS from a single analytical run.(18, 19) This powerful 
tool can be useful for the characterization and identification of different classes or types of 
natural products, including PPAPs and PIBs. 
 
Garcinia paucinervis Chun & F. C. How (Clusiaceae) is an endemic species to mainland China, 
distributed mainly in southwest provinces such as Guangxi and Yunnan. It provides valued 
hardwood, resulting in its being overharvested, and is now considered a Class II endangered 
species in mainland China. In addition to its useful wood, the roots, leaves, and bark can also be 
used as folk medicine for the treatment of bacterial skin infections, bruises, and burns.(20)G. 
paucinervis is known to produce many benzophenones that have biological activity. For 
example, the benzophenone derivatives paucinones A–D, isolated from the leaves of this species, 
showed cytotoxicity against HeLa cells.(21) Currently, there have been over 50 compounds 
including 20 benzophenone derivatives reported from this species.(20-23) 
 
In the past decade, our laboratory has isolated and identified a number of Garcinia prenylated 
benzophenones with cytotoxic activity.(24-28) An interest is retained in cytotoxic 
benzophenones from additional Garcinia species, to better understand their structure–activity 
relationships. This report is focused on G. paucinervis, to better understand the considerable 
chemical diversity from this endangered species. A UPLC-QTOFMSE strategy was used to 
identify benzophenone derivatives from the fractions of G. paucinervis seeds. Five new 
benzophenones (1–5) were isolated, and their structures were elucidated with NMR, IR, and 
electronic circular dichroism (ECD) spectra. In addition, their cytotoxic effects on three 
clinically relevant breast cancer cell lines, MDA-MB-231, SKBR3, and MCF-7, were evaluated. 
 
 
Chart 1 
 
Results and Discussion 
 
An ethanol extract of G. paucinervis seeds was defatted with petroleum ether, and the defatted 
residue was then chromatographed over a column containing silica gel to yield nine fractions. All 
fractions were analyzed by UPLC-QTOFMS, using two modes: (1) an MS full scan, to obtain the 
accurate molecular formulas of detected peaks; and (2) an MSE experiment, to produce fragment 
ions to deduce the potential benzophenone derivates. The benzophenone derivatives were 
detected in nine fractions, and 31 peaks (a–ee) from these fractions were identified as containing 
potential benzophenone derivatives, as supported by the molecular formula, by the diagnostic 
fragment ion (m/z 177.02),(10) and compared to the Garcinia compounds previously indexed in 
the SciFinder database (Chemical Abstracts Service, Columbus, OH, USA). Among them, 19 
peaks were judged to contain known benzophenones, including a number of isomers often with 
similar fragment ions. For instance, peaks o–s (C38H50O7), peaks u–w, z–bb (C38H48O6), and 
peaks x, cc–ee (C38H50O6) were previously reported in Garcinia species (Table S1, Supporting 
Information). The other 12 peaks contained compounds that were classified tentatively as 
benzophenones, due to the loss of prenylated groups, benzene rings, and the diagnostic ion 
at m/z 177.0188 (C9H5O4) observed in the MSE spectrum. On the basis of the comprehensive 
analysis of these 12 peaks, the basic structural units of six compounds were proposed, and these 
were considered to be “unknowns of interest”, warranting further isolation and identification 
work. 
 
Peak g (tR = 3.60 min) eluted closely with peak h (tR = 3.73 min), only observed in fraction E, 
which could be identified as isomeric compounds (C38H44O9), due to both displaying the same 
molecular ions at m/z 645.3070 [M + H]+ and 643.2901 [M – H]−. For peak g, the MSE spectra 
are shown in Figure 1, with the molecular ions and the main fragment ions obtained under the 
low-energy mode. The fragment ion at m/z 509.1809 corresponded to the loss of two prenyl 
groups (2C5H8) from the molecular ions, and it lost a further C5H8 unit to produce an ion 
at m/z 453.1179. While additional ion fragments could be observed in the high-energy mode, a 
continuous loss of C5H4O3, C5H8, C4H8, and C6H6O2 suggested another ion pathway in peak g. 
Such a molecular formula and the basic structure units have not been found previously 
in Garcinia metabolites. Thus, both peaks g and h were targeted as potentially containing 
unknown benzophenone-type structures. Peaks e and f (C33H40O8) and peak b (C27H32O6) were 
also further investigated, using similar reasoning (Figures S1 and S2, Supporting Information). 
 
 
Figure 1. HRMSE spectra and proposed fragmentation pathway of paucinone E (1). 
 
Based on UPLC-QTOFMSE fragment ion analysis on the peaks of the nine G. 
paucinervis fractions, six target peaks (b, e, f, l, g, and h) were considered unknowns of interest. 
They were separated by Sephadex LH-20 chromatography and semipreparative HPLC to obtain 
compounds 1–5. The details of isolation are described in the Experimental Section. Their 
structures are assigned by the means of NMR, MS, IR, and ECD spectroscopy. 
 
Paucinones E (1) and F (2) were obtained as yellow, amorphous powders from peaks g and h, 
respectively, and had the same molecular formula C38H44O9 by HRQTOFMS (m/z 645.3070 [M 
+ H]+ and m/z 645.3063 [M + H]+, calcd 645.3064), representing a hydrogen index deficiency of 
17, and their 1H, 13C, and 2D NMR spectroscopic data were almost identical. The 1H NMR 
spectrum for 1 exhibited seven methyl groups signals [δH 1.01, 1.19, 1.51, 1.55, 1.56, 1.62, and 
1.64], two olefinic proton signals [δH 7.8 (1H, d, J = 5.5 Hz) and 6.4 (1H, d, J = 5.5 Hz)], and 
signals for a trisubstituted aromatic ring [δH 7.10 (1H, d, J = 2.1 Hz), 7.04 (1H, dd, J = 8.2, 2.1 
Hz), and 6.78 (1H, d, J = 8.2 Hz)] (Table 1). The 13C NMR and DEPT spectra of 1 revealed the 
presence of 38 carbon atoms, including three carbonyl carbons, five methylenes, nine methines 
(eight olefinic), seven methyl groups, and 14 quaternary carbons (two sp3 quaternary carbons). 
The HSQC and HMBC spectra demonstrated that 1 contains a trisubstituted aromatic ring, three 
carbonyls, and three prenyl groups. All these moieties indicated that 1 is a prenylated 
benzophenone derivative.(1) The diagnostic chemical shift (δC 41.1) for C-10 in the 13C NMR 
spectrum indicated the 10E geometry in compound 1 as supported by a previous report.(29) In 
addition, H-7 exhibited correlations with the C-6, C-5, and C-9 carbons in the HMBC spectrum 
and allowed the assignment of the geranyl group at the C-6 position. Another prenylated unit was 
attached to the C-6 carbon as well, as supported by the HMBC correlations between protons H-
17 and C-6, C-1, C-7, and C-19. The core structure of 1 (C-1 to C-18) agreed closely with 
previously reported kolanone analogues,(30, 31) isolated from G. kola Heckel seeds. However, 
compound 1 had an additional cyclohexane oxide ring attached at C-3 and C-4, shown by the 
HMBC correlations between H-29/C-3 (δC 169.3), H-30/C-4 (δC 105.3), and Me-32 and Me-
33/C-30 (δC 37.4) and C-31 (δC 79.7), respectively. The remaining five carbons (δC 156.7, 144.0, 
175.5, 114.6, and 155.6) and 1H–1H COSY correlation of H-37/H-38 were in agreement with the 
pyromeconic acid group,(32) which is attached at C-29, as supported by the key HMBC 
correlations of H-29/C-34 and H-30/C-34 (Figure 2), thereby defining the planar structure of 
compound 1 as defined. 
 
 
Figure 2. Key COSY and HMBC of paucinone E (1), paucinone G (3), and paucinone I (5). 
 
Table 1. NMR Spectroscopic Data (300 MHz, CD3OD) for Compounds 1–3 
  1 2 3a 3b 
position δC δH (J in Hz) δC δH (J in Hz) δC δH (J in Hz) δC δH (J in Hz) 
1 189.5   189.2   197.5   197.5   
2 109.4   109.4   128.4   128.3   
3 169.3   169.8   164.3   164.1   
4 105.3   105.6   55.8   55.7   
5 197.6   197.6   204.6   204.6   
6 60.2   60.1   66.5   66.5   
7 39.0 2.74, 2.51, m 39.6 2.70, 2.48, m 37.6 2.64, 2.56, m 37.3 2.63, 2.55, m 
8 119.6 4.95, m 119.9 4.96, m 119.4 4.98, m 119.3 4.99, m 
9 139.5   139.9   141.5   141.0   
10 41.2 1.96, m 41.1 1.94, 1.96, m 41.2 2.02, 1.96, m 41.2 2.00, 1.95, m 
11 27.9 2.01, 1.93, m 27.9 2.01, 1.93, m 28.1 2.09, 1.99, m 27.8 2.07, 1.97, m 
12 125.3 5.08, m 125.2 5.03, m 125.1 5.11, m 125.0 5.08, m 
13 132.5   132.5   132.7   132.7   
14 26.1 1.62, s 26.1 1.64, s 26.1 1.66, s 26.1 1.66, s 
15 18.0 1.55, s 18.0 1.56, s 18.0 1.59, s 18.0 1.59, s 
16 16.7 1.54, s 16.7 1.58, s 16.8 1.57, s 16.6 1.57, s 
17 40.1 2.64, 2.57, m 39.7 2.68, 2.54, m 39.3 2.67, 2.50, m 39.2 2.65, 2.49, m 
18 119.4 4.94, m 119.4 4.92, m 118.9 5.03, m 118.5 5.02, m 
19 136.5   135.6   137.9   137.3   
20 26.4 1.64, s 26.5 1.67, s 18.2 1.55, s 18.2 1.55, s 
21 18.2 1.56, s 18.2 1.51, s 26.4 1.70, s 26.4 1.70, s 
22 193.0   193.6   193.3   193.3   
23 131.9   132.3   130.5   130.5   
24 117.0 7.10, d (2.1) 117.0 7.14, d (2.1) 116.3 7.36, d (2.1) 116.2 7.36, d, (2.1) 
25 146.0   146.0   147.0   147.0   
26 151.3   151.3   153.2   153.2   
27 115.2 6.78, d (8.2) 115.3 6.77, d (8.2) 115.7 6.78, d (8.3) 115.7 6.77, d (8.3) 
28 123.7 7.04, dd (8.2, 2.1) 123.9 7.07, dd (8.2, 2.1) 125.3 7.17, dd (8.3, 2.1) 125.2 7.17, dd (8.3, 2.1) 
29 30.5 4.16, dd (11.2, 6.7) 30.6 4.15, dd (10.9, 6.9) 63.7 4.27, d (1.2) 63.7 4.28, d (1.3) 
30 37.4 2.02, 1.89, m 37.2 2.02, 1.89, m 70.9 4.00, d (1.2) 70.9 3.96, d (1.2) 
31 79.7   79.5   87.0   86.8   
32 28.4 1.01, s 28.4 1.01, s 29.2 1.20, s 29.2 1.20, s 
33 23.9 1.19, s 24.2 1.19, s 23.7 1.38, s 23.6 1.38, s 
34 156.7   156.9           
35 144.0   144.0           
36 175.5   175.6           
37 114.6 6.40, d (5.5) 114.6 6.41, d (5.5)         
38 155.6 7.80, d (5.5) 155.8 7.88, d (5.5)         
 
The 1H NMR spectrum for 2 also exhibited signals for seven methyl groups, one olefinic proton, 
and one trisubstituted aromatic ring (Table 1). The differences between 
compounds 1 and 2 involve the chiral carbons at C-6 and C-29. Compounds 1 and 2 exhibited 
opposite signs for optical rotation values [1, +66, and 2, −74] and almost mirror-image ECD 
spectra (Figure 3). On the basis of the fact that these compounds were separated by a 
nonenantioselective method, compounds 1 and 2 were not considered as being enantiomers but 
rather diasteroisomers. Since NOESY data were not useful in establishing the relative 
configurations of 1 and 2 at these chiral atoms, their absolute configurations were established by 
comparison of their experimental and calculated ECD spectra, as predicted by the time-
dependent density functional theory (TDDFT) approach.(27, 33-36) Molecular modeling 
calculations, such as ECD and optical rotation, have been used to determine the absolute 
configuration of prenylated benzophenones.(27) Thus, a Monte Carlo conformational search 
using the MMFF94 molecular mechanics force field was perform for diasteroisomers 6S, 
29R and 6R, 29R (Figure S3, Supporting Information). For this, and to minimize computational 
time, the aliphatic chains at C-6 were reduced to a methyl group and hydrogen due to the 
numerous conformations generated in the conformational analysis with little or no effect on the 
ECD calculations.(37) The enantiomers 6R, 29S and 6S, 29S were not computed since the ECD-
calculated spectra are antipodal. Then, each conformer was geometrically optimized at the 
B3LYP/DGDZVP level of theory (Figure S3, Supporting Information) with the polarizable 
continuum model (PCM) for methanol, as implemented in the Gaussian 09 software. The 
Boltzmann-averaged ECD spectra of diasteroisomers 6S, 29R and 6R, 29R (Figure 3) based on 
TDDFT showed an excellent fit with the experimentally measured data: (a) diasteroisomer 6S, 
29R showed negative Cotton effects at 260 and 350 nm and a positive Cotton effect at 300 nm, 
which was in good agreement with the experimental data for compound 1; (b) diasteroisomer 6R, 
29R showed a positive Cotton effect at 250 nm and a negative Cotton effect at 330 nm, which 
was in good agreement with the experimental data for compound 2. Thus, the absolute 
configurations of compounds 1 and 2 were determined as 6S, 29R and 6R, 29R, respectively. 
 
 
Figure 3. Experimentally measured ECD spectra of compounds (A) and calculated ECD spectra 
(B) of paucinones E (1, 0.78 mM, MeOH, cell length 2 cm) and F (2, 0.78 mM, MeOH, cell 
length 2 cm). 
 
Paucinone G (3) was obtained from peaks e and f, as a yellow, amorphous powder. Its molecular 
formula was assigned as C33H40O8, based on the 13C NMR data and the molecular ion peaks in 
the HRQTOFMS (m/z 565.2803 [H + M]+, calcd for 565.2801, C33H41O8), and represented 14 
degrees of unsaturation. From the 1H NMR spectrum of 3, seven methyl groups and one 
trisubstituted aromatic ring were observed (Table 1). The 13C NMR and DEPT spectra 
of 3 accounted for 33 carbons, classified as three carbonyls, four methylenes, eight methines, 
seven methyl groups, and 11 quaternary carbons, showing close similarities to those of 1, thus 
suggesting that compound 3 is also a prenylated benzophenone. On comparison of the 1D and 
2D NMR spectra of 3 and 1, the obvious differences were that (1) the signals of a pyromeconic 
acid group were not observed in 3 and (2) there was a carbonyl (δC 197.5) at C-1 of 3, as 
supported by the HMBC correlations of H-7 and H-17/C-1, C-5, and C-6. Furthermore, a 2,2-
dimethyl-3-hydroxypyran moiety was assigned at C-3 and C-4, as confirmed by the HMBC 
correlations between H-29/C-4, C-5 and C-31, H-30/C-4 and C-29, Me-32/C-31 and C-33, and 
Me-33/C-30 and C-31. Other key HMBC and 1H–1H COSY correlations are shown in Figure 2. 
In addition, an oxide ethylene group was proposed at C-4 (δC 55.8) and C-29 (δC 63.7), as 
supported by published reports.(38) Accordingly, the planar structure of 3 is established as 
shown. Compound 3 proved to be a mixture of two isomers, 3a and 3b, since the 1H and 13C 
NMR data displayed two sets of signals (Table 1) with a relative ratio of 1.0:1.2, respectively. 
These isomers have four stereocenters (C-6, C-30, C-4, and C-29); two of them, C-4 and C-29, 
have the same stereochemistry since they are supporting the epoxide group. The signals at 
δH 4.00 (d, J = 1.2 Hz, H-30) and 4.27 (d, J = 1.2 Hz, H-29) for 3a and δH 3.96 (d, J = 1.2 Hz, H-
30) and 4.28 (d, J = 1.3 Hz, H-29) for 3b supported the orientation of stereocenters C-4/29 and 
C-30 as R,R,R or S,S,S. This was in agreement with the dihedral angle (3JHCCH = −114°) between 
H-29 and H-30 obtained by the 3D models generated for each isomer (data not shown). Due to 
the paucity of sample, it was impossible to establish the absolute stereochemistry of these 
isomers. 
 
Paucinone H (4) was purified from peak l, and the HRQTOFMS showed a molecular ion 
at m/z 549.2852 [H + M]+ (calcd for 549.2852, C33H41O7), consistent with a molecular formula 
of C33H40O7, with 14 degrees of unsaturation. Similar to 3, compound 4 was found to be an 
isomeric mixture of 4a and 4b with a relative ratio of 1.0:1.6, respectively, based on the 1H 
and 13C NMR data (Table 2). The spectroscopic data of 4 were similar to those of 3, except for 
C-30 (4: δC 38.0, δH 2.64 and 2.56; 3: δC 70.9, δH 4.00), indicating that C-30 of 4 is an 
sp3 methylene with the hydroxy group signal in 3 missing from 4. The key 1H–1H COSY and 
HMBC correlations of 4 were the same as 3. Therefore, the above evidence was used to propose 
the planar structure of 4. Since C-30 is not chiral, there is no experimental data to support the 
relative orientation of C-4 and C-29. Compound 4 was isolated in limited amounts, so the 
absolute stereochemistry could not be determined experimentally. 
 
Table 2. NMR Spectroscopic Data (300 MHz, CD3OD) for Compounds 4 and 5 
  4a 4b 5 
position δC δH (J in Hz) δC δH (J in Hz) δC δH (J in Hz) 
1 197.7   197.7   212.8   
2 128.5   128.4   115.3   
3 166.2   166.0   181.8   
4 53.0   52.9   202.2   
5 205.5   205.3   56.4   
6 66.8   66.7   34.5 2.38, d (7.3) 
7 35.5 2.45, 2.25, m 35.5 2.44, 2.22, m 119.9 5.04, m 
8 119.4 4.99, m 119.3 4.98, m 140.0   
9 141.3   141.0   41.2 1.97, 1.88, m 
10 41.2 2.02, 1.96, m 41.1 2.02, 1.96, m 27.9 2.10, m 
11 28.1 2.09, 1.99, m 27.8 2.08, 1.93, m 125.4 5.03, m 
12 125.2 5.11, m 125.0 5.10, m 132.4   
13 132.6   132.7   26.0 1.62, s 
14 26.1 1.69, s 26.1 1.66, s 17.9 1.54, s 
15 18.0 1.59, s 18.0 1.59, s 16.4 1.59, s 
16 16.8 1.57, s 16.6 1.55, s 34.3 2.38, m 
  4a 4b 5 
position δC δH (J in Hz) δC δH (J in Hz) δC δH (J in Hz) 
17 39.0 2.67, 2.50, m 38.9 2.66, 2.49, m 120.1 5.04, m 
18 119.0 5.03, m 118.7 5.02, m 135.9   
19 137.4   137.7   26.3 1.64, s 
20 18.2 1.55, s 18.2 1.54, s 18.0 1.59, s 
21 26.3 1.70, s 26.3 1.70, s 194.5   
22 193.6   193.6   132.4   
23 130.6   130.6   117.2 7.35, d (1.9) 
24 116.3 7.37, d (2.1) 116.2 7.36, d (1.9) 146.2   
25 147.0   147.0   151.8   
26 153.2   153.2   115.3 6.71, d (8.2) 
27 115.8 6.77, d (8.3) 115.7 6.76, d (8.3) 125.5 7.25, dd (8.3, 1.9) 
28 125.4 7.19, dd (8.3, 2.1) 125.2 7.18, dd (8.3, 2.1)     
29 61.0 4.28, m 60.8 4.26, m     
30 38.0 2.64, 2.56, m 37.7 2.63, 2.52, m     
31 83.6   83.5       
32 31.2 1.16 31.2 1.16, s     
33 29.7 1.41 29.6 1.41, s     
 
In addition, 3 and 4 are similar structures, which was also supported by UPLC-
QTOFMSE analysis, since the compounds exhibit similar fragment peaks (Figure S1, Supporting 
Information). 
 
Paucinone I (5), an orange powder, was obtained from peak b. The HRQTOFMS molecular ion 
peak at m/z 453.2279 [H + M]+ (calcd for 453.2279, C27H33O6) corresponded to its molecular 
formula of C27H32O6, with 12 degrees of unsaturation. The 1H NMR spectrum displayed signals 
for a trisubstituted aromatic ring [δ 7.35 (1H, d, J = 1.9 Hz), 7.25 (1H, dd, J = 8.3, 1.9 Hz), and 
6.71 (1H, d, J = 8.2 Hz)], and five methyl groups [δH 1.54 (3H, s), 1.59 (6H, br s), 1.62 (3H, s), 
and 1.64 (3H, s)]. The 13C NMR of 5 showed 27 carbon signals, assigned to three carbonyl 
carbons, five methyl groups, four methylenes, six methines, and nine quaternary carbons (Table 
2). These NMR data were generally similar to those of 3, which, supported by the key HMBC 
correlations of H-6/C-1, C-4, C-5, C-8; H-9/C-7, C-8, C-15; H-16/C-1, C-4, C-5, C-18; and H-
23/C-21, H-27/C21, respectively (Figure 2), indicate that a geranyl group and a prenylated unit 
are attached to C-5 and a trisubstituted aromatic ring is linked to carbonyl carbon (C-21, 
δC 194.5). The remaining two carbons (C-2 and C-3) along with C-1, C-4, and C-5 constituted a 
pentacyclic structure. The hydroxy group is attached at C-3, as demonstrated by the high 
chemical shift at δC 181.8. The above evidence was used to elucidate the planar structure of 5. 
The configuration at C-5 was established unequivocally by comparing the specific rotation value 
with that obtained through molecular modeling calculations for the enantiomers C-5S and C-5R, 
following the same protocol described for compounds 1 and 2 using the Gaussian 09 program 
(Figure S4, Supporting Information). Comparison of the experimental ([α]25D = −27) and the 
calculated ([α]25D = −22) specific rotation values allowed the absolute configuration of 
compound 5 to be determined as 5S. 
 
The five isolated compounds (1–5) were evaluated for cytotoxicity against human breast cancer 
cells using a WST assay. Three cancer cell lines, MDA-MB-231, SKBR3, and MCF-7, were 
used for this study. However, none of the compounds tested were deemed cytotoxic for any of 
the cell lines used (IC50 < 10 μM). 
 
Experimental Section 
 
General Experimental Procedures 
 
Optical rotations were measured on an Autopol IV polarimeter (Rudolph Research Analytical, 
Hackettstown, NJ, USA) equipped with a sodium lamp (589 nm) and a 10 cm microcell. UV 
spectra were recorded on a Evolution 300 UV–vis spectrometer (Thermo Scientific). IR spectra 
were measured on a Nicolet iS10 (Thermo Scientific). ECD spectra were determined using a 
circular dichroism spectrometer model 202–-01 (Aviv Biomedical, Lakewood, NJ, USA) and 
recorded at 589 nm from 25 °C using 1 mm quartz cells. A Bruker Avance 300 NMR 
spectrometer was operated at 300.1312 MHz for 1H and at 75.4753 MHz for 13C NMR 
experiments. UPLC-QTOFMS was operated using an Acquity UPLC system (Waters 
Corporation, Milford, MA, USA) coupled with a QTOF-MS (Xevo G2 QTOF, Waters MS 
Technologies, Manchester, UK), controlled by MassLynx v4.1 software. HPLC separations used 
a Waters 2695 separation module, equipped with a Waters 2996 photodiode array detector, with 
an HPLC column (Synergi 4 μm Hydro-RP 80 Å, 250 × 4.6 mm, Phenomenex) for analysis, 
while semipreparative HPLC was carried out on an Econosil C18 column (10 μm, 250 × 10 mm, 
Grace Alltech). Sephadex LH-20 (25–100 μm, Pharmacia Fine Chemicals, Piscataway, NJ, 
USA) and HPLC-MS grade acetonitrile, water, and formic acid were purchased from J. T. Baker 
(Philipsburg, NJ, USA). Thin-layer chromatography silica gel plates and silica gel 200–300 mesh 
(Qingdao Haiyang Chemical Co. Ltd. Qingdao, People’s Republic of China) were used, and all 
reagents were analytical grade (Beijing Chemical Works, Beijing, People’s Republic of China). 
 
Plant Material 
 
Garcinia paucinervis seeds were collected in July 2014 from Xishuangbanna, Yunnan Province, 
in People’s Republic of China, and the specimens were identified by one of the authors (C.L.L.). 
The voucher specimens (herbarium no. 20144538) were deposited in the Herbarium of Minzu 
University of China in Beijing, People’s Republic of China. 
 
Extraction and Isolation 
 
Air-dried G. paucinervis seeds (1 kg) were ground into a powder and extracted twice with 2 L of 
95% ethanol soaked for 48 h. The filtered solution was concentrated under reduced pressure at 
40 °C to yield a crude extract (320 g). Water (800 mL) was added to dissolve the crude extract. 
The same volume of petroleum ether was used for solvent–solvent partitioning, and the upper 
phase (petroleum extract) was removed (140 g). The residue (120 g) was purified by silica gel 
column chromatography (120 × 10 cm), eluted with a gradient solvent system of petroleum 
ether–acetone (100:0 → 0:100, 800 mL collected volumes of each fraction), and concentrated, 
affording nine combined fractions (Fr. A–Fr. I, 0.5, 2.2, 2.1, 1.5, 2.0, 7.8, 13.2, 5.1, and 6.0 g, 
respectively). Each fraction was then analyzed by UPLC-QTOFMS before preparative-scale 
isolation work commenced. 
 
Fraction D (1.0 g) was chromatographed over Sephadex LH-20 (150 × 2.5 cm, MeOH) to afford 
five subfractions (Fr. D1–Fr. D5). Fr. D4 (280 mg) was subsequently purified by reversed-phase 
preparative HPLC using gradient elution [MeCN–H2O with 0.1% formic acid, 60:40 → 63:37 
over 25 min] to obtain compound 3 (tR: 15 min, 20 mg) and compound 4 (tR: 22 min, 10.5 mg). 
Compound 3 was further purified by analytical HPLC with isocratic elution [MeCN–H2O 
(52:48)], with a flow rate of 1.5 mL/min, to yield 12.5 mg (tR: 26 min). Fraction E (250 mg) was 
purified by semipreparative HPLC with isocratic elution [MeCN/H2O with 0.1% formic acid 
(45:55)] with a flow rate of 3 mL/min, yielding compounds 1 (tR: 27 min, 18.0 mg) and 2 (tR: 31 
min, 12.0 mg). Fraction I (700 mg) was chromatographed over Sephadex LH-20 (150 × 2.5 cm) 
to give six subfractions (Fr. I1–Fr. I6). Fr. I3 (200 mg) was repeatedly chromatographed by 
reversed-phase HPLC, eluting with a step gradient from 65% to 70% MeOH, giving 
compound 5 (tR: 10 min, 15.0 mg). 
 
Paucinone E (1): 
 
yellow, amorphous powder; [α]25D +66 (c 0.6, MeOH); UV (MeOH) λmax (log ε) 204 (2.47), 260 
(0.67), 287 (0.93) nm; ECD (MeOH, Δε) λmax 236 (−36.2), 280 (+14.5) nm; IR (MeOH) 
νmax 3317, 2944, 2832, 1449, 1115, 1022 cm–1; 1H and 13C NMR (methanol-d4, 300 MHz) data, 
see Table 1; HRESIMS m/z 645.3070 [M + H]+ (calcd for C38H45O9, 645.3064). 
 
Paucinone F (2): 
 
yellow, amorphous powder; [α]25D −74 (c 0.35, MeOH); UV (MeOH) λmax (log ε) 205 (2.65), 
260 (0.77), 285 (1.06) nm; ECD (MeOH, Δε) λmax 236 (+50), 344 (−15.5) nm; IR (MeOH) 
νmax 3315, 2943, 2831, 1449, 1115, 1022 cm–1; 1H and 13C NMR (methanol-d4, 300 MHz) data, 
see Table 1; HRESIMS m/z 645.3063 [M + H]+ (calcd for C38H45O9, 645.3064). 
 
Paucinone G (3): 
 
yellow, amorphous powder; UV (MeOH) λmax (log ε) 205 (2.58), 236 (1.63), 275 (1.64) nm; IR 
(MeOH) νmax 3316, 2943, 2831, 1449, 1115, 1022 cm–1; 1H and 13C NMR (methanol-d4, 300 
MHz) data, see Table 1; HRESIMS m/z 565.2803 [M + H]+ (calcd for C33H41O8, 565.2801). 
 
Paucinone H (4): 
 
yellow, amorphous powder; UV (MeOH) λmax (log ε) 204 (2.33), 235 (1.30), 277 (1.24) nm; IR 
(MeOH) νmax 3312, 2943, 2831, 1449, 1115, 1022 cm–1; 1H and 13C NMR (methanol-d4, 300 
MHz) data, see Table 2; HRESIMS m/z 549.2849 [M + H]+ (calcd for C33H41O7, 549.2852). 
 
Paucinone I (5): 
 
orange, amorphous powder; [α]25D −27 (c 0.22, MeOH); UV (MeOH) λmax (log ε) 206 (2.83), 
251 (0.70), 283 (1.32), 321 (1.14) nm; IR (MeOH) νmax 3312, 2943, 2831, 1449, 1115, 1022 cm–
1; 1H and 13C NMR (methanol-d4, 300 MHz) data, see Table 2; HRESIMS m/z 453.2278 [M + 
H]+ (calcd for C27H33O6, 453.2277). 
 
UPLC-QTOFMS Analysis 
 
Chromatographic separation was performed with a 2.1 × 50 mm i.d., 1.7 μm UPLC BEH 
C18 reversed-phase column and kept at a temperature of 40 °C. The mobile phase consisted of 
0.1% aqueous formic acid (A) and 0.1% formic acid in acetonitrile (B). The linear gradient 
elution was performed as follows: 0–0.5 min, 20% B; 0.5–2.5 min, 20–65% B; 2.5–5 min, 65–
70% B; 5–7.5 min, 70–75% B; 7.5–11.0 min, 75–95% B; 11.0–12.8 min, 95–95% B; 12.8–13.2 
min, 95–20% B; 13.2–15.0 min, 20–20% B. A flow rate of 0.4 mL/min was employed for 
elution, and the injected sample (2 mg/mL) volume was set at 1 μL. Mass spectrometry was 
recorded using a Xevo G2 QTOF equipped with an ESI source and controlled by MassLynx v4.1 
software. The MS and MSE data resolution modes of scans were applied. MS full scanning was 
conducted in both positive ion and negative ion modes over the range m/z 100–1000 Da in two 
channels, with a scan time of 0.5 s. The capillary voltages were set at 3100 V (positive mode) 
and 2500 V (negative mode), respectively, and the cone voltage was 20 V. Nitrogen gas was 
used both for the nebulizer and in desolvation. The desolvation and cone gas flow rates were 600 
and 20 L/h, respectively. The desolvation temperature was 400 °C, and the source temperature 
was 120 °C. The MSE experiments were conducted in the centroid configuration in the positive 
mode, with a range of m/z 50–1000 Da, and survey scan time was 0.5 s, the low energy was set 
as 5 V, while the high energy was ramped from 25 to 50 V. The cone voltage was set as 60 V. 
The lock mass solution of leucine enkephalin (1 μg/mL) in acetonitrile–water (1:1) containing 
0.1% formic acid was utilized as the lock mass at a flow rate of 10 μL/mL, with m/z 556.2771 for 
the positive mode and m/z 554.2615 for the negative mode. 
 
Molecular Modeling Calculations 
 
Theoretical calculations of ECD spectra for diasteroisomers 1 and 2 were performed with the 
Gaussian 09 (Gaussian Inc., Wallingford, CT, USA) program package as described 
previously.(27, 33-36) Briefly, geometry optimizations and conformer distribution analysis for 
all structures were carried out using the MMFF94 molecular mechanics force field calculations 
as implemented in the Spartan 08 program (Wavefunction Inc., Irvine, CA, USA).(39) A Monte 
Carlo search protocol(40) was carried out considering an energy cutoff of 5 kcal/mol. For each 
structure, all minimum energy conformers were filtered and checked for duplicity and then 
geometrically optimized using the hybrid DFT method B3LYP and the basis set DGDZVP 
(B3LYP/DGDZVP), with thermochemical parameters and frequencies at 298 K and 1 atm. Their 
thermochemical properties, optical rotation, IR, and vibrational analyses were calculated at the 
same level. The self-consistent reaction field method (SCRF) with the conductor-like screening 
model (COSMO) was employed to perform the ECD calculations of major conformers for each 
compound in their respective solvent solution with the same basis set. The calculated excitation 
energy (in nm) and rotatory strength R, in dipole velocity (Rvel) and dipole length (Rlen) forms, 
were simulated into an ECD curve by using the following Gaussian function:
where σ is the width of the band at 1/e height 
and Ei and Ri are the excitation energies and rotatory strengths for transition i, respectively. σ = 
0.40 eV and Rvel were used. The Boltzmann-averaged ECD spectra were obtained from 
B3LYP/DGDZVP-optimized structures. All quantum calculations were carried out on a Linux 
operating system in the KanBalam cluster from a Hewlett-Packard HP CP 4000, which includes 
1368 AMD Opteron processors at 2.6 GHz and a RAM memory of 3 terabytes (KanBalam, 
Dirección General de Cómputo y de Tecnologías de Información y Comunicación, UNAM, 
Mexico City, Mexico). For each task, up to 16 processors were used, and each conformer 
required three different DFT tasks: geometric optimizations, frequency calculations, and TD 
ECD calculations. The free energy equation (ΔG = −RT ln K) was used to obtain the 
conformational population, taking into account a cyclic equilibrium at 298 K between the 
selected conformers of each structure within a 0.0–5.0 kcal/mol window with respect to the 
global minimum. The free energy values ΔG° were obtained from the vibrational frequency 
calculations as the sum of electronic and thermal free energies. 
 
Growth Inhibitory Effects on a Panel of Breast Cancer Cells 
 
All compounds tested in vitro were dissolved in DMSO and diluted with required volumes of 
respective cell culture media before each treatment. The volume of DMSO did not exceed 
0.001% in the wells after treatment. MDA-MB-231 and MCF7 cells were cultured in DMEM 
glucose medium (Gibco, USA) supplemented with 10% fetal calf serum and 100 μL of 
antibiotics (penicillin and streptomycin). SKBR3 cells were cultured in DMEM F12 glutamine 
medium supplemented with 10% fetal calf serum and 100 μL of antibiotics (penicillin and 
streptomycin). All cells were maintained at 37 °C in an incubator with 5% CO2. To determine 
the cytotoxicity effects of the test compounds on the three cell lines mentioned above, 
exponentially growing cells (12 × 103 cells/well) were seeded in 96-well multitier plates. After 
24 h, each test compound was added to each cell line used for this study. Concentrations of the 
compounds studied ranged from 5 to 200 μM. Doxorubicin was used as a positive control. After 
48 h treatment, a cell viability assay (WST) was performed. Each well was washed twice with 
serum-free medium followed by the addition of a 10% WST solution. This solution (150 μL) was 
then added to each well. The plates were wrapped in aluminum foil and incubated for 1 h; their 
absorbance was then read at 440 nm using a Spectra Max plate reader. Each experiment was 
performed in triplicate. Average absorbance and the percentage inhibition relative to the control 
were calculated. The results were analyzed using Graph Pad Prism Software (Graph Pad 
Software, San Diego, CA, USA), and IC50 values were estimated. 
 
Supporting Information 
 
The Supporting Information is available free of charge on the ACS Publications website at 
DOI: 10.1021/acs.jnatprod.6b00186. 
 
The authors declare no competing financial interest. 
 
Acknowledgment 
 
The authors wish to thank Dr. Y. Xu, Hunter College, CUNY, for measuring ECD spectra of 
compounds; Dr. B. Zajc, City College, CUNY, for acquiring the optical rotation data; and Ms. J. 
Kwok for culturing cell lines. Dr. B. Liu and Dr. W. Cao from Minzu University of China are 
recognized for carrying out field work and harvesting the plant material used in this study. We 
would also like to thank the Dirección General de Cómputo y de Tecnologías de Información y 
Comunicación (DGTIC-UNAM) for providing the resources to carry out computational 
calculations through the KanBalam system. This work was supported by the Ministry of 
Education of China through its 111 Program and the Discipline Development Program for Minzu 
University of China (B08044, YLDX01013, and 2015MDTD16C), the National Natural Science 
Foundation of China (3116140345 and 31070288), the China Scholarship Council (CSC), and 
the Graduate Research and Innovation Project of Minzu University of China (Z2014045). 
Support was also provided by a CUNY Collaborative grant to J.E.F. and E.J.K. 
 
References 
 
1. Wu, S. B.; Long, C.; Kennelly, E. J. Nat. Prod. Rep. 2014, 31, 1158– 1174 DOI: 
10.1039/C4NP00027G  
2. Ciochina, R.; Grossman, R. B. Chem. Rev. 2006, 106, 3963– 3986 DOI: 10.1021/cr0500582  
3. Kumar, S.; Sharma, S.; Chattopadhyay, S. K. Fitoterapia 2013, 89, 86– 125 DOI: 
10.1016/j.fitote.2013.05.010  
4. Fu, Y.; Zhou, H.; Wang, M.; Cen, J.; Wei, Q. J. Agric. Food Chem. 2014, 62, 4127– 4134 
DOI: 10.1021/jf405790q  
5. Yamaguchi, F.; Saito, M.; Ariga, T.; Yoshimura, Y.; Nakazawa, H. J. Agric. Food 
Chem. 2000, 48, 2320– 2325 DOI: 10.1021/jf990908c  
6. Liu, X.; Yu, T.; Gao, X. M.; Zhou, Y.; Qiao, C. F.; Peng, Y.; Chen, S. L.; Luo, K. Q.; Xu, H. 
X. J. Nat. Prod. 2010, 73, 1355– 1359 DOI: 10.1021/np100156w  
7. Feng, C.; Huang, S. X.; Gao, X. M.; Xu, H. X.; Luo, K. Q. J. Nat. Prod. 2014, 77, 1111– 1116 
DOI: 10.1021/np4007316  
8. Acuña, U. M.; Jancovski, N.; Kennelly, E. J. Curr. Top. Med. Chem. 2009, 9, 1560– 1580 
DOI: 10.2174/156802609789909830  
9. Fan, Y. M.; Yi, P.; Li, Y.; Yan, C.; Huang, T.; Gu, W.; Ma, Y.; Huang, L. J.; Zhang, J. 
X.; Yang, C. L. Org. Lett. 2015, 17, 2066– 2069 DOI: 10.1021/acs.orglett.5b00588  
10. Zhou, Y.; Huang, S. X.; Song, J. Z.; Qiao, C. F.; Li, S. L.; Han, Q. B.; Xu, H. X. J. Am. Soc. 
Mass Spectrom. 2009, 20, 1846– 1850 DOI: 10.1016/j.jasms.2009.06.008  
11. Stark, T. D.; Losch, S.; Wakamatsu, J.; Balemba, O. B.; Frank, O.; Hofmann, T. J. Agric. 
Food Chem. 2015, 63, 7169– 7179 DOI: 10.1021/acs.jafc.5b02544  
12. Abad-Garcia, B.; Berrueta, L. A.; Garmon-Lobato, S.; Gallo, B.; Vicente, F. J. Chromatogr. 
A 2009, 1216, 5398– 5415 DOI: 10.1016/j.chroma.2009.05.039  
13. Yang, M.; Sun, J.; Lu, Z.; Chen, G.; Guan, S.; Liu, X.; Jiang, B.; Ye, M.; Guo, D. A. J. 
Chromatogr. A 2009, 1216, 2045– 2062 DOI: 10.1016/j.chroma.2008.08.097  
14. Nielsen, K. F.; Mansson, M.; Rank, C.; Frisvad, J. C.; Larsen, T. O. J. Nat. 
Prod. 2011, 74, 2338– 2348 DOI: 10.1021/np200254t  
15. Piccinelli, A. L.; Campone, L.; Dal Piaz, F.; Cuesta-Rubio, O.; Rastrelli, L. J. Am. Soc. Mass 
Spectrom. 2009, 20, 1688– 1698 DOI: 10.1016/j.jasms.2009.05.004  
16. Zhou, Y.; Lee, S.; Choi, F. F.; Xu, G.; Liu, X.; Song, J. Z.; Li, S. L.; Qiao, C. F.; Xu, H. 
X. Anal. Chim. Acta 2010, 678, 96– 107 DOI: 10.1016/j.aca.2010.08.010  
17. Wrona, M.; Mauriala, T.; Bateman, K. P.; Mortishire-Smith, R. J.; O’Connor, D. Rapid 
Commun. Mass Spectrom. 2005, 19, 2597– 2602 DOI: 10.1002/rcm.2101  
18. Plumb, R. S.; Johnson, K. A.; Rainville, P.; Smith, B. W.; Wilson, I. D.; Castro-Perez, J. 
M.; Nicholson, J. K. Rapid Commun. Mass Spectrom. 2006, 20, 1989– 1994 DOI: 
10.1002/rcm.2550  
19. Ramirez-Ambrosi, M.; Abad-Garcia, B.; Viloria-Bernal, M.; Garmon-Lobato, S.; Berrueta, 
L. A.; Gallo, B. J. Chromatogr. A 2013, 1316, 78– 91 DOI: 10.1016/j.chroma.2013.09.075  
20. Fan, Q.; Na, Z.; Hu, H.; Xu, Y.; Tang, T. Chin. Trad. Herbal Drugs 2012, 43, 436– 439 
21. Gao, X. M.; Yu, T.; Lai, F. S. F.; Pu, J. X.; Qiao, C. F.; Zhou, Y.; Liu, X.; Song, J. Z.; Luo, 
K. Q.; Xu, H.-X. Tetrahedron Lett. 2010, 51, 2442– 2446 DOI: 10.1016/j.tetlet.2010.02.147  
22. Wu, Y. P.; Zhao, W.; Xia, Z. Y.; Kong, G. H.; Lu, X. P.; Hu, Q. F.; Gao, X. 
M. Molecules 2013, 18, 9663– 9669 DOI: 10.3390/molecules18089663  
23. Gao, X. M.; Yu, T.; Lai, F. S.; Zhou, Y.; Liu, X.; Qiao, C. F.; Song, J. Z.; Chen, S. L.; Luo, 
K. Q.; Xu, H. X. Bioorg. Med. Chem. 2010, 18, 4957– 4964 DOI: 10.1016/j.bmc.2010.06.014  
24. Baggett, S.; Protiva, P.; Mazzola, E. P.; Yang, H.; Ressler, E. T.; Basile, M. J.; Weinstein, I. 
B.; Kennelly, E. J. J. Nat. Prod. 2005, 68, 354– 360 DOI: 10.1021/np0497595  
25. Protiva, P.; Hopkins, M. E.; Baggett, S.; Yang, H.; Lipkin, M.; Holt, P. R.; Kennelly, E. 
J.; Bernard, W. I. Int. J. Cancer 2008, 123, 687– 694 DOI: 10.1002/ijc.23515  
26. Yang, H.; Figueroa, M.; To, S.; Baggett, S.; Jiang, B.; Basile, M. J.; Weinstein, I. 
B.; Kennelly, E. J. J. Agric. Food Chem. 2010, 58, 4749– 4755 DOI: 10.1021/jf9046094  
27. Acuña, U. M.; Figueroa, M.; Kavalier, A.; Jancovski, N.; Basile, M. J.; Kennelly, E. J. J. Nat. 
Prod. 2010, 73, 1775– 1779 DOI: 10.1021/np100322d  
28. Einbond, L. S.; Mighty, J.; Kashiwazaki, R.; Figueroa, M.; Jalees, F.; Acuna, U. M.; Le 
Gendre, O.; Foster, D. A.; Kennelly, E. J. Anti-Cancer Agents Med. 
Chem. 2013, 13, 1540– 1550 DOI: 10.2174/18715206113139990095  
29. Chiang, Y. M.; Kuo, Y. H.; Oota, S.; Fukuyama, Y. J. Nat. Prod. 2003, 66, 1070– 1073 DOI: 
10.1021/np030065q  
30. Raikar, S. B.; Nuhant, P.; Delpech, B.; Marazano, C. Eur. J. Org. 
Chem. 2008, 2008, 1358– 1369 DOI: 10.1002/ejoc.200701009  
31. Hussain, R. A.; Owegby, A. G.; Parimoo, P.; Waterman, P. G. Planta Med. 1982, 44, 78– 81 
DOI: 10.1055/s-2007-971406  
32. Hashidoko, Y. Biosci., Biotechnol., Biochem. 1995, 59, 886– 890 DOI: 10.1271/bbb.59.886  
33. Bringmann, G.; Bruhn, T.; Maksimenka, K.; Hemberger, Y. Eur. J. Org. 
Chem. 2009, 17, 2717– 2727 DOI: 10.1002/ejoc.200801121  
34. Ding, Y.; Li, X. C.; Ferreira, D. J. Nat. Prod. 2009, 72, 327– 335 DOI: 10.1021/np800146v  
35. Stephens, P. J.; Harada, N. Chirality 2010, 22, 229– 233 DOI: 10.1002/chir.20733  
36. Stephens, P. J.; Pan, J. J.; Devlin, F. J.; Urbanova, M.; Hajicek, J. J. Org. 
Chem. 2007, 72, 2508– 2524 DOI: 10.1021/jo062567p  
37. Piao, S. J.; Jiao, W. H.; Yang, F.; Yi, Y. H.; Di, Y. T.; Han, B. N.; Lin, H. W. Mar. 
Drugs 2014, 12, 4096– 4109 DOI: 10.3390/md12074096  
38. Yurchenko, A. N.; Smetanina, O. F.; Khudyakova, Y. V.; Kirichuk, N. N.; Chaikina, E. 
L.; Anisimov, M. M.; Afiyatullov, S. S. Chem. Nat. Compd. 2013, 49, 857– 860 DOI: 
10.1007/s10600-013-0764-0  
39. Kong, J.; White, C. A.; Krylov, A. I.; Sherrill, D.; Adamson, R. D.; Furlani, T. R.; Lee, M. 
S.; Lee, A. M.; Gwaltney, S. R.; Adams, T. R.; Ochsenfeld, C.; Gilbert, A. T. B.; Kedziora, G. 
S.; Rassolov, V. A.; Maurice, D. R.; Nair, N.; Shao, Y.; Besley, N. A.; Maslen, P. 
E.; Dombroski, J. P.; Daschel, H.; Zhang, W.; Korambath, P. P.; Baker, J.; Byrd, E. F. C.; Van 
Voorhis, T.; Oumi, M.; Hirata, S.; Hsu, C.-P.; Ishikawa, N.; Florian, J.; Warshel, A.; Johnson, B. 
G.; Gill, P. M. W.; Head-Gordon, M.; Pople, J. A. J. Comput. Chem. 2000, 21, 1532– 1548 DOI: 
10.1002/1096-987X(200012)21:16<1532::AID-JCC10>3.0.CO;2-W  
40. Chang, G.; Guida, W. C.; Still, W. C. J. Am. Chem. Soc. 1989, 111, 4379– 4386 DOI: 
10.1021/ja00194a035 
